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Background: The success of gene therapy asks for the development of multifunctional vectors 
that could overcome various gene delivery barriers, such as the cell membrane, endosomal 
membrane, and nuclear membrane. Layer-by-layer technique is an efficient method with easy 
operation which can be used for the assembly of multifunctional gene carriers. This work 
describes a pH-sensitive multifunctional gene vector that offered long circulation property but 
avoided the inhibition of tumor cellular uptake of gene carriers associated with the use of 
polyethylene glycol.
Methods: Deoxyribonucleic acid (DNA) was firstly condensed with protamine into a cationic 
core which was used as assembly template. Then, additional layers of anionic DNA, cationic 
liposomes, and o-carboxymethyl-chitosan (CMCS) were alternately adsorbed onto the template 
via layer-by-layer technique and finally the multifunctional vector called CMCS-cationic 
liposome-coated DNA/protamine/DNA complexes (CLDPD) was constructed. For in vitro test, 
the cytotoxicity and transfection investigation was carried out on HepG2 cell line. For in vivo 
evaluation, CMCS-CLDPD was intratumorally injected into tumor-bearing mice and the tumor 
cells were isolated for fluorescence determination of transfection efficiency.
Results: CMCS-CLDPD had ellipsoidal shapes and showed “core-shell” structure which showed 
stabilization property in serum and effective protection of DNA from nuclease   degradation. 
In vitro and in vivo transfection results demonstrated that CMCS-CLDPD had pH-sensitivity 
and the outermost layer of CMCS fell off in the tumor tissue, which could not only protect 
  CMCS-CLDPD from serum interaction but also enhance gene transfection efficiency.
Conclusion: These results demonstrated that multifunctional CMCS-CLDPD had 
  pH-  sensitivity, which may provide a new approach for the antitumor gene delivery.
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Introduction
Gene therapy has offered highly possible promises for treatment of cancers, as many 
potential therapeutic genes involved in regulation of molecular processes may be 
introduced by gene transfer, which can arrest angiogenesis, tumor growth, invasion, 
metastasis, and/or stimulate the immune response against tumors.1 However, the initial 
enthusiasm for cancer gene therapy has been dampened by poor efficiency of the 
delivery systems.2 To date, viral vectors are still the most efficient systems for gene 
transfer but the limitations associated with their use, in terms of risks of mutagenesis, 
safety, immunogenicity, and high production costs, have encouraged researchers to 
focus on alternative nonviral systems.3,4
In order to achieve efficient gene delivery into the nucleus of target cells, nonviral 
systems must overcome several barriers, such as circulation barriers, target tissue 
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distribution, cellular endocytosis, endosomal escape, and 
nucleus entry. Therefore, various functional elements, such 
as ligands for specific targeting, fusogenic lipids or 
pH-sensitive polymers for endosomal escape, and nuclear 
localization signals for enhanced nuclear entry, are needed 
to be equipped into the nonviral gene delivery system to form 
a multifunctional gene vector.5 However, it is difficult to 
integrate all these functional devices into a single system by 
simple mixing and to have each function exerted at the 
appropriate time and correct place.6 To date, two approaches 
have been widely used to construct multifunctional vectors: 
chemical modification of block copolymers subsequently 
assembled with deoxyribonucleic acid (DNA) to form 
micelles and incorporation of functional devices into lipid-
based gene vectors. In this study, the intention was to propose 
a new approach called layer-by-layer (LbL) self-assembly 
to construct multifunctional vectors.
LbL technique, first introduced at the beginning of the 
1990s by Gero Decher, was used to assemble multilayered 
films with alternate deposition of polycations and   polyanions.7 
Based on electrostatic or other intermolecular forces, it 
presents a new approach to the formation of supramolecular 
architectures. As DNA is anionic charged and can be self-
assembled with cationic polymers, it can be incorporated 
into multilayered films by LbL technique and these DNA-
loaded multilayered films have been used as nonviral gene 
delivery system.8,9 LbL assembly offers numerous   advantages. 
Firstly, it is entirely aqueous and scarcely involves organic 
solvents, which is beneficial to maintain the activity of 
DNA.10 Secondly, it can control DNA loading by controlling 
film thickness or the number of layers of DNA deposited 
during fabrication.11 Thirdly, application of functional poly-
electrolytes can assign multilayered films with different 
functions including cell targeting, controlled release of DNA 
in physiological condition, enhanced membrane penetration, 
and intracellular targeting.12,13 With the rapid development 
of LbL technique, gene delivery systems constructed via LbL 
technique have been extended from planar films to three-
dimensional “core-shell” nanoparticles. For example, 
  Trubetskoy et al demonstrated that the recharging of poly-
ethylenimine (PEI)/DNA polyplexes using poly(acrylic acid) 
could be used to increase levels of cell transfection in vitro 
in the presence of serum and increase levels of gene 
  expression in the lung in vivo.14 Saul et al constructed PEI-
DNA-poly(acrylic acid)-PEI quaternary complexes and the 
increased association of PEI achieved by the multilayer 
approach lead to substantial increases in expression of trans-
gene for reporter plasmids without the need for excess free 
polymer typically required for nonviral gene delivery.15 With 
programmed deposition of required functional polyanions 
and polycations, LbL assembly has the potential to achieve 
highly sophisticated programmable control of gene delivery. 
Therefore, it can be concluded that a multifunctional nano-
vector could be designed with programmed assembly of 
functional polyanions and polycations to help overcome 
biological barriers for gene transfer. Compared with the 
widely used chemical modification method to fabricate 
multifunctional gene vectors, LbL is an easy method without 
complicated chemical modification which avoids losing 
original functionality of polymers or lipids.16 As multilayers 
built by the LbL method afford a more stable coating than 
those prepared by lipid incorporation because of the strong 
electrostatic attractions between layer to layer and layer to 
substrate, LbL also solves the problem of randomness and 
poor reproducibility associated with lipidic incorporation of 
functional ligands and LbL offers a degree of stable modifica-
tion to functional ligands.17
In this study, after choosing the required functional 
components to overcome the barriers of gene delivery, such 
as pH-sensitive polymer for long circulation time, fusogenic 
lipids for endosomal escape, and a nuclear localization 
signal for enhanced nuclear delivery, a new multifunctional 
nanovector was constructed via LbL technique. In order to 
have each function exerted at the appropriate time and cor-
rect place, programmed assembly of these functional 
materials was indispensable. Firstly, protamine (Pro), which 
showed improvement in both nuclear targeting and intra-
nuclear transcription,18 was used to condense DNA into a 
compact core as the template for the following assembly. 
Then, an additional layer of DNA was deposited onto the 
template to form DNA/Pro/DNA complexes (DPD). This 
additional DNA layer could increase DNA loading and also 
reverse the cationic surface charge of Pro/DNA for further 
assembly. After that, a cationic lipid layer of cationic lipo-
somes for endosomal escape, which were prepared with 
cationic lipid 6-lauroxyhexyl lysinate (LHLN) previously 
synthesized by the authors’ group and 1,2-dioleoyl-
  sn-glycero-3-phosphoethanolamine (DOPE), was assem-
bled onto the surface of anionic DPD, and thus cationic 
liposome-coated DPD (CLDPD) were obtained. As polysac-
charide coating is the most common biomimic strategy, a 
derivate of chitosan – anionic o-carboxymethyl-chitosan 
(CMCS) – was chosen as the outermost layer which would 
be assembled onto CLDPD to form multifunctional CMCS-
CLDPD. The CMCS coating offered long circulation 
property but avoided the inhibition of tumor cellular uptake 
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of gene carriers associated with the use of hydrophilic 
polymers (ie,   polyethylene glycol). It was interesting that 
the outermost CMCS layer had pH-  sensitivity, which pos-
sessed cationic charges under pH 6.5 and was anionic 
charged above pH 7.0. Therefore, in blood circulation, 
CMCS was anionic charged and adsorbed on the surface 
of CLDPD, which could protect the cationic CLDPD against 
serum interaction and offered long circulation capability. 
When arriving at the acidic environment of tumor tissue, 
CMCS was cationic charged, repelled with CLDPD, and 
fell off. The exposed cationic CLDPD combined with 
negatively-charged cell membrane was internalized via 
endocytosis. With the help of the fusogenic lipid DOPE, 
CLDPD could escape from endosomes and release the DPD 
in cytoserum. The loaded DNA was then translocated into 
nucleus under the guidance of the nuclear targeting poly-
peptide Pro. Therefore, a high efficient multifunctional gene 
vector which offered long circulation, efficient cellular 
membrane transport, endosomal escape, high DNA loading, 
and nuclear targeting was fabricated for tumor gene 
  delivery. This delivery process of CMCS-CLDPD is illus-
trated in Figure 1. The physicochemical property and 
in vitro and in vivo transfection efficiency of CMCS-
CLDPD were tested in this study. In vitro and in vivo studies 
showed that the outermost CMCS layer could fall off in the 
acidic   environment of tumor tissue and expose CLDPD, 
which enhances gene transfection efficiency. Results indi-
cated that the   multifunctional CMCS-CLDPD might pro-
vide a new approach for antitumor gene delivery.
Materials and methods
Materials
The pEGFP-N1 vector was provided by Zhejiang University 
(Hangzhou, China). PicoGreen® reagent was purchased from 
Invitrogen Life Technologies (Carlsbad, CA). Pro was 
obtained from Sigma-Aldrich Corporation (St Louis, MO). 
DOPE was obtained from Avanti Polar Lipids, Inc, 
  (Alabaster, AL). CMCS (Mr 50000, carboxymethyl degree 
of substitution 60%) was purchased from Jinan Haidebei 
Marine Bioengineering Co, Ltd, (Jinan, China). Agarose 
was purchased from Biowest (Nuaille, France). Goldview 
was obtained from Beijing Saibaisheng Biological Engineer-
ing Co, Ltd, (Beijing, China). MTT (3-[4,5-dimethyl-2-
thiazolyl]-2,5-diphenyl-  2H-tetrazolium bromide) was 
purchased from Sigma-Aldrich. Lipofectamine™ 2000 was 
obtained from Invitrogen. Human liver carcinoma (HepG2) 
and mouse melanoma (B16) cells were obtained from the 
American Type Culture Collection (Manassas, VA). DNase I 
enzyme and buffer were obtained from Beijing Yinfeng 
Century Scientific Develop Co, Ltd, (Beijing, China). 
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Figure 1 Schematic representation of multifunctional o-carboxymethyl-chitosan cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes 
delivery process. 
Abbreviations: CMCS, o-carboxymethyl-chitosan; CLDPD, cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes; DNA, deoxyribonucleic 
acid; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine.
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  Heparin was delivered by the Institute of Biochemical and 
  Biotechnological Drug of Shandong   University (Jinan, 
China). Deionized water was used   throughout the experi-
ment. All other chemicals and reagents used were of analyti-
cal purity grade or higher, obtained commercially.
Animals
Kunming mice weighing 18–22 g were supplied by the 
  Medical Animal Test Center of the New Drugs Evaluation 
Center, Shandong University (Jinan, China). All animal 
experiments complied with the requirements of the National 
Act on the Use of Experimental Animals (China).
Preparation of CMCS-CLDPD
Initially, 100 µL of 50 µg/mL aqueous solution of plasmid 
DNA was added dropwise to 100 µL of 100 µg/mL Pro 
solutions under gentle vortexing for 20 seconds. The sample 
was incubated at room temperature for 30 minutes to facilitate 
the formation of Pro/DNA complexes.19 Then, an isovolumic 
solution of DNA was added dropwise to Pro/DNA and the 
sample was incubated at room temperature for 30 minutes 
to facilitate the formation of DPD. After that, DPD were 
stored at 4°C until use. LHLN was synthesized using the 
method described previously.20 LHLN was dissolved in 
dehydrated alcohol and mixed with a helper lipid DOPE 
(1:1 molar ratio). The mixture was evaporated to dryness in 
a round-bottomed flask using a rotary evaporator at room 
temperature. The resulting lipid film was dried by nitrogen 
for an additional 10 minutes to evaporate any dehydrated 
alcohol. After that, DPD was added to the round-bottomed 
flask. The flask was then gently vibrated to facilitate hydra-
tion of the lipid film and sonicated using a Sonic Dismembra-
tor (Model 500; Thermo Fisher   Scientific, Pittsburgh, PA) 
for 5 minutes at room temperature to form homogenized 
CLDPD. The obtained CLDPD suspension was put into an 
Eppendorf tube (Eppendorf AG, Hamburg, Germany). Under 
weak vortex conditions, CMCS was added dropwise and 
incubated for 30 minutes at room temperature. Finally, 
CMCS-CLDPD was obtained. The preparation process of 
CMCS-CLDPD is illustrated in Figure 2.
DNA
DNA
Pro/DNA
Pro
DNA/Pro/DNA
(DPD)
CLDPD
pH 7.4 CMCS
CMCS-CLDPD
Cationic liposomes
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Figure  2  Schematic  representation  of  the  assembly  process  of  multifunctional  o-carboxymethyl-chitosan  cationic  liposome-coated  deoxyribonucleic  acid/protamine/
deoxyribonucleic acid complexes. 
Abbreviations: CMCS, o-carboxymethyl-chitosan; CLDPD, cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes; DNA, deoxyribonucleic 
acid; Pro, protamine.
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Characterization of DPD, CLDPD,  
and CMCS-CLDPD
The surface morphology of DPD, CLDPD, and CMCS-
CLDPD was examined by transmission electronic microscopy 
(JEM-1200EX; JEOL Ltd, Tokyo, Japan). Samples were 
prepared respectively by placing a drop of three kinds of 
nanoparticle suspensions onto a copper grid and air drying, 
followed by negative staining with one drop of 3% aqueous 
solution of sodium phosphotungstate (Sigma-Aldrich) for 
contrast enhancement. The air-dried samples were then 
directly examined under the transmission electron   microscope. 
Mean particle size and zeta potential of the three kinds of 
nanoparticle suspensions were analyzed by photon correla-
tion spectroscopy with a Zetasizer® 3000 (Malvern 
  Instruments, Malvern, UK). All measurements were carried 
out in triplicate. The average particle size was expressed as 
volume mean diameter and the reported value was repre-
sented as mean ± standard deviation (n = 3).
pH sensitivity analysis of CMCS-CLDPD
In previous studies focused on drug delivery, the determi-
nation of drugs released from carriers at different pH 
values was often used to evaluate the pH-sensitivity of 
carriers.21 It was expected that the outermost layer of 
CMCS would fall off from the surface of CMCS-CLDPD 
in the acidic environment of tumors. Therefore, in order 
to evaluate the pH sensitivity of CMCS-CLDPD, the in 
vitro release of DNA from CMCS-CLDPD in 50 mM 
phosphate buffer solution (PBS) with different pH values 
(pH 5.5, 6.0, 6.5, 7.0, 7.4) was   determined. Typically, an 
aliquot of CMCS-CLDPD (equivalent to 2.5 µg DNA) was 
suspended in 1 mL PBS at pH 5.5 in Eppendorf tubes in 
a 37°C shaking water bath at 100 rpm. Separate tubes were 
used for each time point. At predetermined time intervals, 
the CMCS-CLDPD suspensions were centrifuged (15,000 
rpm for 30 minutes) and the amount of DNA released in 
the supernatant was analyzed using fluorospectrophotometry 
with PicoGreen™ double-stranded DNA quantitative 
reagent.22 Background readings were obtained using the 
supernatants from PBS at pH 5.5. Fluorescence was mea-
sured by fluorescence spectrophotometer (model 850; 
Hitachi High-Technologies, Tokyo, Japan) at excitation 
and emission wavelengths of 480 nm and 520 nm, respec-
tively. The amount of DNA was calculated according to 
the linear calibration curve of DNA (F = 0.0850C + 0.1132, 
R = 0.9996). The in vitro release of DNA at other values 
(pH 6.0, 6.5, 7.0, 7.4) was respectively performed with 
the same procedure. Also, zeta potential of CMCS-CLDPD 
after incubation in PBS with different pH values (pH 5.5, 
6.0, 6.5, 7.0, 7.4) was analyzed by photon correlation 
spectroscopy.
DNase I protection assay
To test whether CMCS-CLDPD could protect loaded DNA 
from nuclease digestion, DNase I-mediated digestion was 
evaluated using agarose gel electrophoresis. In brief, 20 µL 
of CMCS-CLDPD containing 1 µg of DNA was incubated 
with DNase I (0.2 U/µg DNA) in DNase I buffer. The suspen-
sions were incubated in a shaking water bath at 37°C and 100 
rpm for 1, 2, and 4 hours, respectively. Naked DNA (1 µg) 
treated with DNase I at 0.2 U/µg DNA in DNase I buffer were 
incubated in a shaking water bath at 37°C and 100 rpm for 
30 minutes. The enzymatic digestion reaction was terminated 
with ethylenediaminetetraacetic acid solution (0.5 M, pH 8.0). 
To separate DNA from CMCS-CLDPD, TE buffer (10 mM 
tris(hydroxymethyl)aminomethane-hydrochloride, 1 mM 
ethylenediaminetetraacetic acid, pH 7.4) containing 1% 
heparin and 1% Triton X-100 (Sigma-Aldrich) was added to 
the suspensions. The suspensions were then placed in a 37°C 
shaking water bath at 100 rpm for 2 hours. After that, the 
suspension was analyzed by gel electrophoresis as described 
above. Untreated DNA was applied to the gel as a control.
Stability study in the presence of serum
To estimate the stability of CMCS-CLDPD, the turbidity 
change of CMCS-CLDPD suspension in the serum was 
evaluated in a previous report.23 A freshly prepared CMCS-
CLDPD solution (250 µL) was added to 1 mL of serum at 
pH 7.4 and the mixed solution was incubated at 37°C with 
mild stirring. The turbidity change of the mixed solution was 
measured using an ultraviolet-visible spectrophotometer 
(UV-2102PC; UNICO, Dayton, NJ) at 450 nm.
Cells culture
HepG2 and B16 cells were cultured in Roswell Park Memo-
rial Institute (RPMI) 1640 medium supplemented with 10% 
fetal bovine serum, streptomycin at 100 µg/mL, and penicillin 
at 100 U/mL. All cells were cultured in a 37°C incubator 
with 5% carbon dioxide.
In vitro cell viability
Cell viability studies were investigated by MTT assay using 
HepG2 cells as model cells.24 HepG2 cells were seeded in 
Corning® Costar® 96-well plates (Sigma-Aldrich) at a density 
of 8 × 103 viable cells per well in 0.2 mL RPMI 1640 supple-
mented with 10% fetal bovine serum and antibiotics. After 
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incubation in a 5% carbon dioxide incubator at 37°C for 
24 hours, the culture medium was replaced by 200 µL fresh 
RPMI 1640 containing different concentrations of CMCS-
CLDPD (0.1–0.5 mg/mL) and the corresponding CLDPD. 
The cells were then incubated for another 24 hours. 
With the same DNA dose, PEI/DNA polyplexes (N/P ratio 
10.0) – widely applied in gene delivery – were used as 
positive control.25 Cell viability was then assessed by MTT 
assay: 5 mg/mL of MTT in PBS was added to each well 
and the plate was incubated for an additional 4 hours at 
37°C in a 5% carbon dioxide incubator. Then the MTT-
containing medium was removed and the crystals formed 
by living cells were dissolved in 100 µL dimethyl sulfoxide. 
Absorbance at 570 nm was determined by a microplate 
reader (Model 680; Bio-Rad Laboratories, Hercules, CA). 
Untreated cells were taken as a control with 100% viability 
and cells without addition of MTT were used as a blank to 
calibrate the spectrophotometer to zero absorbance.   Relative 
cell viability (%) compared to control cells was calculated 
by (Abssample/  Abscontrol) × 100. All experiments were repeated 
in triplicate.
In vitro transfection studies
The transfection activity of CMCS-CLDPD was evaluated 
using plasmid DNA, encoding enhanced green fluorescence 
protein (EGFP) as reporter gene in the transfection studies. 
HepG2 cells were seeded in six-well plates at a density of 
3 × 105 cells per well and incubated overnight at 37°C in 
2 mL of complete RPMI 1640 culture medium. At a conflu-
ence level of 70%–80%, the growth medium was removed 
and the cells were washed twice with PBS buffer. The 
medium was replaced with serum free medium (pH 7.4), 
serum free medium (pH 6.5), and 20% serum medium 
(pH 7.4), respectively. CMCS-CLDPD containing 5 µg of 
DNA was then added. All transfections were carried out in 
three wells each. Naked DNA and PEI/DNA (N/P 10.0) were 
used as negative control and positive control, respectively. 
The cells were incubated with the test complexes for 4 hours 
at 37°C before replacing with fresh medium for 48 hours. 
  Fluorescence in cells was observed using an inverted fluo-
rescence microscope (excitation: 540 nm and emission: 
580 nm; BX40; Olympus Corporation, Tokyo, Japan). The 
fluorescent images were obtained using a DP70 digital imag-
ing system (Olympus) analyzed by Olysia BioReport imaging 
software (v 3.2; Olympus). After that, all cells were harvested 
for trypsinization and washed in PBS three times, and cell- 
associated fluorescence was quantitatively determined by a 
FACSCalibur™ flow cytometer (BD Biosciences, San Jose, CA) 
by counting 10,000 events. Only the viable cells were gated 
for   fluorescence analysis.
In vivo transfection studies
Each Kunming mouse was inoculated subcutaneously in the 
subaxillary region with 8 × 106 B16 cells. The tumor growth 
was monitored by measuring tumor length (L) and width (W) 
with a caliper every 2 days. The tumor volume (V) was 
calculated as V = 1/2 × L2 × W. When the tumor reached 
300–400 mm3, mice were randomly assigned to four groups 
(six mice in each group). CMCS-CLDPD and CLDPD 
(100 µL, containing 10 µg pEGFP) were intratumorally 
injected four times with a 12-hour interval. Naked DNA was 
used as a negative control and PEI/DNA (N/P 10.0) was used 
as a positive control, both of which were intratumorally 
injected with the same dosage of pEGFP. The mice were 
sacrificed 72 hours or 96 hours after the first injection and 
the tumor tissue samples were taken out. The tumor tissues 
were homogenized by pressing the samples through a 30 µm 
cell mesh with the plunger of a 10 mL syringe; erythrocyte 
lysis buffer was added during homogenization to lyse the red 
blood cells. The homogenates were washed three times with 
PBS containing 0.5% bovine serum albumin and then filtered 
(30 µm CellTrics®; Partec GmbH, Munster, Germany). The 
cells were finally obtained after centrifugation (4°C, 
1000 rpm, 5 minutes) and were seeded into 24-well plates 
in 1 mL of Dulbecco’s Modified Eagle’s Medium with 10% 
fetal bovine serum. The fluorescent cells were observed using 
an inversion fluorescence microscope and pictures taken. 
The pictures were analyzed with Image-Pro Plus software 
(v 7.0; Media Cybernatics Inc, Silver Spring, MD) to calcu-
late total fluorescence intensity of tumor cells.
Statistical analysis
All studies were repeated a minimum of three times and 
measured at least in triplicate. Results were reported as 
mean ± standard deviation. Statistical significance was 
analyzed using Student’s t-test. Differences between experi-
mental groups were considered significant when P , 0.05.
Results
Optimization of CMCS-CLDPD
The influence of DNA on the formation of DPD
Pro/DNA complexes were prepared at N/P mass ratio of 
2.5. Gel retarding analysis was used to optimize the appropri-
ate mass ratio (DNA: Pro/DNA ternary complexes) required 
for the formulation of DPD. Once DNA was deposited onto 
the surface of Pro/DNA complexes, the mobility of DNA was 
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retarded and it remained in the hole of the agarose gel. 
  Fluorescence could be seen in the holes from Lane 3 to Lane 6 
(Figure 3). The part of DNA which did not bind onto the 
surface of Pro/DNA complexes migrated to the positive elec-
trode in the same manner with the control DNA. As illustrated 
in Figure 3, an additional DNA layer was successfully depos-
ited onto the surface of Pro/DNA when the mass ratio was 
above 1:8. However, too high mass ratio might cause too much 
free DNA in the suspension, which was unfavorable to the 
deposition of additional cationic LHLN-liposomes layer.
Mass ratios of LHLN-liposomes  
to DPD for preparation of CLDPD
As the mass ratios of LHLN-liposomes to DPD increased, 
the particle size of CLDPD increased (Table 1). Zeta potential 
of DPD was −19.3 ± 2.8 mV (Table 1). However, when the 
mass ratio increased to 10:1, zeta potential reversed to posi-
tive charges, demonstrating that the cationic LHLN-lipo-
somes were successfully adsorbed onto the surface of DPD. 
When the mass ratio was higher than 50:1, zeta potential of 
CLDPD remained unchanged, demonstrating that the surface 
of DPD had been saturated with cationic LHLN-liposomes. 
The transmission electron microscopic images of CLDPD 
prepared with different mass ratios are illustrated in Figure 4. 
It was found that CLDPD prepared at mass ratio 25:1 were 
particles without spherical morphology, which showed that 
they were partially encapsulated with LHLN-liposomes. 
When the mass ratio was 50:1, CLDPD showed spherical 
shapes with a fairly narrow size distribution. However, when 
the mass ratio increased to 75:1, CLDPD severely aggregated 
and the particle size was 469.3 ± 6.3 nm, demonstrating that 
this mass ratio was too high for the assembly of CLDPD. 
Therefore, the mass ratio of 50:1, which offered high surface 
charge for CLDPD, was finally chosen for further 
assembly.
Mass ratios of CMCS to CLDPD  
for preparation of CMCS-CLDPD
Zeta potential reversed when the mass ratio of CMCS to 
CLDPD was 1:1, demonstrating the successful deposition of 
DNA 1234 56
Pro/DNA 1:10 1:8 1:6 1:4 1:2
The mass ratios of DNA:Pro/DNA
Figure 3 gel retarding analysis of deoxyribonucleic acid/protamine/deoxyribonucleic 
acid complexes prepared with different mass ratios. 
Abbreviations: DNA, deoxyribonucleic acid; Pro, protamine.
Table 1 Particle size and zeta potential of cationic liposome-
coated  deoxyribonucleic  acid/protamine/deoxyribonucleic  acid 
complexes prepared with different mass ratios
Mass ratios  
(LHLN-liposomes:DPD)
Mean diameter  
(nm) ± SD
Zeta potential 
(mV) ± SD
0 128.7 ± 2.6 −19.3 ± 2.8
10:1 134.6 ± 2.9 3.2 ± 2.1
25:1 158.5 ± 3.4 15.6 ± 3.1
50:1 180.6 ± 4.7 24.3 ± 4.3
75:1 469.3 ± 6.3 27.7 ± 3.8
Abbreviations: LHLN, 6-lauroxyhexyl lysinate; DPD, DNA/Pro/DNA complexes.
ABC
100 nm 100 nm 100 nm
Figure 4 Transmission electron microscopic imaging of cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes with different mass 
ratios: (A) 25:1, (B) 50:1, (C) and 75:1.
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CMCS on the surface of CLDPD (Figure 5). When the mass 
ratio was higher than 2.5:1, zeta potential of CMCS-CLDPD 
remained almost the same and it could be concluded that 
CMCS had already saturated the surface of CLDPD. In order 
to avoid the existence of excess CMCS which might influence 
the biological properties of gene vectors, the mass ratio of 
2.5:1 was chosen as the optimization of CMCS-CLDPD.
Physicochemical properties  
of CMCS-CLDPD
CMCS-CLDPD were successfully prepared via LbL tech-
nique and characterized in terms of morphology, particle 
size, and surface charge. As illustrated in Figure 6, Pro/DNA 
complex, DPD, CLDPD, and CMCS-CLDPD all showed 
spherical or ellipsoidal shapes. With the sequential deposi-
tion of DNA, LHLN-liposomes, and CMCS layer, a layered 
structure was found on the surface of the corresponding 
DPD, CLDPD, and CMCS-CLDPD, which   demonstrated 
the   formation of CMCS-CLDPD with multilayered 
  structure. The physicochemical characteristics of different 
nanoparticles are summarized in Table 2. As the assembly 
process proceeded, the particle size increased from 
100.2 ± 3.4 nm of Pro/DNA to 210.9 ± 6.8 nm of CMCS-
CLDPD. All the particles exhibited narrow size distribu-
tions (polydispersity index ,0.3). As shown in Figure 7, 
when Pro/DNA complex was coated with a layer of DNA, 
zeta potential reversed to −12.5 ± 3.2 mV and switched 
back to positive when further coated by another layer of 
LHLN-liposomes. After the deposition of the last layer of 
CMCS, the zeta potential reversed from positive to negative 
values again and CMCS-CLDPD achieved a zeta potential 
of −8.9 ± 2.7 mV .
pH sensitivity analysis of CMCS-CLDPD
At the same time point (t . 12 hours), the cumulative release 
of DNA in PBS with different pH values followed the 
inequality: pH 5.5 . pH 6.0 . pH 6.5 . (pH 7.0, pH 7.4) 
(P , 0.05; Figure 8). It could be concluded that the loaded 
DNA was released from CMCS-CLDPD more quickly in 
acid medium than in neutral medium. In order to demonstrate 
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Figure 6 Transmission electron microscopic imaging of different nanoparticles: (A) Protamine (Pro)/deoxyribonucleic acid (DNA) complex, (B) DNA/Pro/DNA complexes, 
(C) Cationic liposome-coated DNA/Pro/DNA complexes, and (D) o-carboxymethyl-chitosan cationic liposome-coated DNA/Pro/DNA complexes.
Table  2  The  particle  size  and  zeta  potential  of  different 
nanoparticles
Sample Mean diameter 
(nm) ± SD
Polydispersity 
index (PDI)
Zeta potential 
(mV) ± SD
Pro/DNA 100.2 ± 3.4 0.165 19.4 ± 2.3
DPD 128.7 ± 2.6 0.134 −12.5 ± 3.2
CLDPD 180.6 ± 4.7 0.182 24.3 ± 4.3
CMCS- 
CLDPD
210.9 ± 6.8 0.221 −8.9 ± 2.7
Abbreviations: DPD, DNA/Pro/DNA complexes; CLDPD, CMCS-cationic liposome-
coated DNA/protamine/DNA complexes; CMCS, o-carboxymethyl-chitosan.
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whether this pH sensitivity release was caused by the 
  disassociation of the outermost layer of CMCS, zeta potential 
of CMCS-CLDPD after incubation in PBS with different pH 
values was determined. As illustrated in Figure 9, zeta poten-
tial of CMCS-CLDPD reversed from negative to positive 
values when the pH of medium was below 6.5, indicating 
that CMCS could fall off from the surface of CMCS-CLDPD 
at pH below 6.5. Therefore, CMCS-CLDPD showed pH 
sensitivity and the outermost layer of CMCS could fall off 
in response to acid medium.
Stability of CMCS-CLDPD against DNase I
For effective gene expression, DNA in the gene vehicle 
should be protected from degradation by enzymes.26 To test 
whether CMCS-CLDPD could protect the loaded plasmid 
DNA from digestion by nucleases, they were exposed to 
DNase I at various time intervals. As illustrated in Figure 10, 
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Figure  8  In  vitro  release  of  deoxyribonucleic  acid  from  o-carboxymethyl-chitosan  cationic  liposome-coated  deoxyribonucleic  acid/protamine/deoxyribonucleic  acid 
complexes in phosphate buffer solution with different pH.
Abbreviation: h, hours.
naked plasmid DNA (lane 5) was completely digested within 
30 minutes of incubation with the DNase I (0.2 U/µg DNA). 
However, after 2 hours of degradation, DNA in CMCS-
CLDPD still showed a relatively complete structure as 
indicated by the presence of supercoiled DNA. Results 
showed that CMCS-CLDPD could protect DNA against 
degradation by DNase I, which is one of the crucial factors 
for efficient gene delivery in vitro as well as in vivo.
Serum stability of CMCS-CLDPD
Serum stability of CMCS-CLDPD was evaluated by determin-
ing the turbidity changes of CMCS-CLDPD after incubation 
with serum. CLDPD was used as control to estimate the effect 
of CMCS on preventing aggregation of CLDPD induced by 
serum. Figure 11 shows the turbidity changes of CLDPD and 
CMCS-CLDPD after incubation with serum. CLDPD with 
high positive charges started to aggregate once mixed with serum. 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
933
Multifunctional nanovector assembled via layer-by-layer techniqueInternational Journal of Nanomedicine 2012:7
As time increased, large aggregates began to precipitate, result-
ing in turbidity decrease. However, particle aggregation 
induced by serum protein was completely prevented after the 
coating of CMCS layer, and the turbidity of CMCS-CLDPD 
remained almost the same as time went by. A possible expla-
nation could be that high anionic surface charge of CMCS 
prevented serum protein adsorption onto CMCS-CLDPD. 
Therefore, CMCS-CLDPD had high serum stability and might 
be suitable for in vivo gene delivery.
Cytotoxicity of CMCS-CLDPD
The in vitro cytotoxicity of CMCS-CLDPD at various 
concentrations (100, 200, 300, 400, and 500 µg/mL) was 
evaluated in HepG2 cells by MTT assay. As shown in 
Figure 12, the cell viabilities of HepG2 cells in the presence 
of CMCS-CLDPD over the studied concentration range 
(100–500 µg/mL) and their corresponding CLDPD were 
all significantly higher than that of PEI/DNA (P , 0.05) 
with the same DNA dose, demonstrating that they exhibit 
lower cytotoxicity than PEI/DNA. CMCS-CLDPD with 
400 µg/mL concentration and the corresponding CLDPD 
were used for in vitro transfection test. At an even higher 
concentration of 500 µg/mL, CMCS-CLDPD showed 
higher cell viability than the corresponding CLDPD 
(P , 0.05).
In vitro transfection results  
of CMCS-CLDPD
Pictures from inversion fluorescence microscope presenting 
the green fluorescence in transfected HepG2 cells are shown 
in Figure 13A. It was found that CMCS-CLDPD, CLDPD, 
and PEI/DNA could successfully transfer HepG2 cells in 
48 hours. The gene transfection efficiency was further 
quantitatively determined by flow cytometry (Figure 13B). 
When the pH value of the transfection medium without 
serum was 7.4, the transfection efficiency of different vec-
tors followed the relationship: CLDPD . PEI/DNA . 
CMCS-CLDPD (P , 0.05). However, when the pH value 
of the transfection medium without serum was 6.5, both 
CMCS-CLDPD and CLDPD showed higher transfection 
efficiency than PEI/DNA (P , 0.05) and CMCS-CLDPD 
obtained almost the same value as CLDPD (P . 0.05). It 
could be concluded that the outermost anionic layer of 
CMCS might fall off at pH 6.5 and then expose the cationic 
CLDPD, which enhances transfection efficiency. In the 
transfection medium with 20% serum (pH 7.4), CMCS-
CLDPD displayed the highest transfection efficiency, which 
showed that CMCS-CLDPD had the best stability in serum 
and could highly transfect HepG2 cells even in the presence 
of serum.
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12345
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Supercoiled
Figure 10 Agarose gel electrophoresis analysis of o-carboxymethyl-chitosan cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes 
after incubation with DNase I. Lane 1: deoxyribonucleic acid control; Lane 2–4: o-carboxymethyl-chitosan cationic liposome-coated deoxyribonucleic acid/protamine/
deoxyribonucleic acid complexes incubated with DNase I for 0.5, 1, and 2 hours, respectively; Lane 5: naked deoxyribonucleic acid incubated with DNase I for 0.5 hours. 
Abbreviations:  CMCS,  o-carboxymethyl-chitosan;  CLDPD,  cationic  liposome-coated  deoxyribonucleic  acid/protamine/deoxyribonucleic  acid  complexes;  DNA, 
deoxyribonucleic acid; DNAc, deoxyribonucleic acid control.
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Figure 11 Absorbance changes of vectors after incubation with serum.
Abbreviations:  A,  absorbance;  CMCS,  o-carboxymethyl-chitosan;  CLDPD, 
cationic  liposome-coated  deoxyribonucleic  acid/protamine/deoxyribonucleic  acid 
complexes; h, hours.
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In vivo transfection results  
of CMCS-CLDPD
After intratumoral injection of naked DNA, PEI/DNA, 
CLDPD, and CMCS-CLDPD into tumor-bearing mice, mice 
were sacrificed and tumor cells were isolated at predeter-
mined time intervals. The fluorescent cells transfected with 
pEGFP were observed using an inverted fluorescence micro-
scope. As illustrated in Figure 14, blank tumor cells isolated 
from mice without any treatment had some slight green 
autofluorescence and were used as a negative control. Naked 
DNA could barely transfect tumor cells and caused almost 
no green fluorescence. After administration, PEI/DNA, 
CLDPD, and CMCS-CLDPD showed higher transfection 
efficiencies at 96 hours than at 72 hours (P , 0.05). 
  Anionic-charged CMCS-CLDPD displayed similar transfec-
tion efficiency to cationic-charged CLDPD (P . 0.05).
Discussion
The purpose of this study was attempting to construct a 
multifunctional vector for efficient gene delivery via LbL 
technique, using alternate layers of polyanions and polyca-
tions with required functionalities. With a deep understand-
ing of gene delivery process, it is acknowledged that 
efficient gene delivery asks for multifunctional gene vectors 
that possess long circulation time, cellular or tissue target-
ing, endosomal escape, and nuclear targeting.27 Thus, in 
this study, Pro with nuclear targeting capability was used 
to condense DNA to form a cationic core, which was used 
100
0
20
40
60
80
100
120 *
* *
* *
* *
*
*
**
200 300 400 500
CMCS-CLDPD concentration (µg/mL)
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
)
CLDPD CMCS-CLDPD PEI/DNA
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Figure 13 (A) Fluorescent micrographs and (B) Flow cytometry results of Hepg2 cells transfected by pEgFP with o-carboxymethyl-chitosan cationic liposome-coated 
deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes and corresponding cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid 
complexes (containing 5 µg deoxyribonucleic acid) in the absence of serum with pH 6.5 and pH 7.4, respectively, and also in the presence of 20% serum (pH 7.4). 
Polyethylenimine/deoxyribonucleic acid (N/P ratio 10.0) prepared with 5 µg deoxyribonucleic acid was used as positive control. gene expression was examined after 
48 hours posttransfection. 
Notes: *P , 0.05; **P , 0.01. 
Abbreviations: CMCS, o-carboxymethyl-chitosan; CLDPD, cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes; DNA, deoxyribonucleic 
acid; PEI, polyethylenimine.
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as assembly template. Then, additional layers of DNA for 
higher loading, LHLN-liposomes for endosomal escape, 
and pH-sensitive CMCS for long circulation time were 
sequentially assembled onto the template. DNA was subtly 
used as an additional layer which could not only reverse the 
surface charge from positive to negative values for further 
deposition of cationic LHLN-liposomes but also increase the 
DNA loading of the vectors. In a previous study, LHLN was 
respectively used as a cationic modifier to prepare solid lipid 
nanoparticles and PLA-  polyethylene glycol nanoparticles, 
which improved transfection efficiency and lowered 
cytotoxicity.20,28 Recently, as a cationic lipid it was mixed 
with fusogenic lipid DOPE, which always had endosomal 
escape capability, to prepare cationic LHLN-liposomes.29 
It was demonstrated that they showed comparable transfec-
tion efficiency to commercial Lipofectamine™ 2000 but with 
lower cytotoxicity. Based on these results, LHLN-liposomes 
were served as a cationic functional material to assemble the 
multifunctional gene vector.
Traditionally, attachment of polyethylene glycol had 
previously been found to be very useful for reducing unde-
sired serum interactions and improving circulation time of 
gene carriers.30,31 However, polyethylene glycol shielding 
lowered transfection efficiency due to reduced cell-surface 
interactions.32,33 This hurdle has been partly overcome by 
inclusion of targeting ligands, but these targeted and 
  pegylated carriers do not reach the activity of the uncoated 
  positively-charged vectors.34,35 It is obvious that polyethylene 
glycol chains should be detached after reaching the target 
cell. For tumor gene delivery, intratumoral pH value in solid 
tumors may drop to 6.5, one pH unit lower than in normal 
blood (7.4), because of hypoxia and massive cell death inside 
the tumor.36 Therefore, pH-sensitive linkages that were quite 
stable at pH around 7.4 but degrade at pH around 6.5 were 
developed to detach polyethylene glycol chains from 
gene carriers in the acidic conditions of tumor tissues based 
on the diorto esters,37 vinyl esters,38 and hydrazones.39 But 
the chemical approaches are complicated and laborious.
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Figure 14 (A) Fluorescent micrographs and (B) Total fluorescence intensity of tumor cells isolated from tumor-bearing mice transfected by pEGFP after intratumoral 
injection of o-carboxymethyl-chitosan cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes and corresponding cationic liposome-coated 
deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes (containing 40 µg deoxyribonucleic acid). Naked deoxyribonucleic acid and polyethylenimine/deoxyribonucleic 
acid (N/P ratio 10.0) with 40 µg deoxyribonucleic acid administered via intratumoral injection were used as negative control and positive control, respectively. 
Note: *P . 0.05. 
Abbreviations: CMCS, o-carboxymethyl-chitosan; CLDPD, cationic liposome-coated deoxyribonucleic acid/protamine/deoxyribonucleic acid complexes; DNA, deoxyribonucleic 
acid; h, hours; PEI, polyethylenimine.
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In this study, an attempt was made to propose a new 
pH-sensitive deshielding of hydrophilic polymer based on 
CMCS. CMCS, a water-soluble derivative of chitosan 
obtained by introducing –CH2–COOH groups onto –OH 
along the chitosan molecular chain, is an amphoteric poly-
electrolyte containing both carboxyl and amino groups.40 It 
can change the charged states of the carboxyl and amino 
groups by varying pH. Therefore, CMCS has good pH and 
ion sensitivity, and is used as a material that can help provide 
pH sensitivity in aqueous solution.41 In the present study, a 
kind of CMCS with carboxymethyl degree of substitution 
60% was used. It was found that when the pH value was 
below or equal to 6.5, the amino groups protonated and 
CMCS fell off from the surface of CMCS-CLDPD (Figure 9; 
reversed surface charge at pH 6.5) because of the electrostatic 
repulsion between the positively-charged CLDPD and 
CMCS. However, when the pH value was above 7.0, carboxyl 
groups ionized and CMCS was negatively charged which 
strongly bound with cationic CLDPD. Therefore, in blood 
circulation with pH 7.4, CMCS would strongly bind with 
cationic CLDPD and protect the gene carrier from serum 
interaction (Figure 11). When in the acidic environment of 
tumor tissue, CMCS was deshielded and CLDPD exposed, 
which then enhanced gene delivery efficiency. This new 
responsive approach is an easy method without use of organic 
solvents and complicated chemical modification, which helps 
to maintain biological activity of DNA. It would be of great 
value for tumor gene therapy.
For LbL technique, electrostatic interactions are widely 
reported to be the main driving force for the multilayer for-
mation process between two oppositely charged polyelec-
trolytes.42 Morphology, particle size, and zeta potential of 
vectors are often determined in order to assess whether an 
additional layer could be successfully deposited on its 
  previous template. As illustrated in Figure 6, the layered and 
“core-shell” structure visually exhibited the successful 
assembly of multilayered CMCS-CLDPD. Moreover, the 
increased particle size and reversed zeta potential of particles 
shown in Table 2 and Figure 7 strongly demonstrate the 
construction of CMCS-CLDPD. During the assembly 
  process, charge overcompensation by adsorbing polyelec-
trolytes, which leads to a reversal of the net surface charge, 
is considered to be a prerequisite for polyelectrolyte multi-
layer formation as it allows the subsequent adsorption of 
oppositely-charged polyelectrolytes through electrostatic 
association.43 The amount of diffusing polyelectrolyte added 
during a deposition step should not only exceed the minimum 
amount needed to neutralize the surface charges of its 
  adsorbing multilayer but also create sufficient new charges 
(ie, net surface charge) for further buildup.44 Usually, the 
surface of multilayer for further buildup was saturated by 
adsorbed polyelectrolytes and its zeta potential no longer 
changed with addition of excess polyelectrolytes.
There is an increasing body of evidence demonstrating 
that the surface properties of nanoparticles can lead to con-
siderable toxicity.45 Cationic agents with high charge density 
have been shown to induce membrane toxicity due to the 
electrostatic interactions with the negatively-charged glyco-
calyx of the cellular surface.46,47 Therefore, lower positive 
charge density or even negative surface charge could reduce 
cytotoxicity.48 This explanation is in accordance with the 
results illustrated in Figure 12. The deposition of anionic 
layer of CMCS on the surface of cationic CLDPD resulted 
in CMCS-CLDPD being negatively charged, so at the highest 
concentration in the test, cell viability of CMCS-CLDPD 
was higher than CLDPD (P , 0.05). Both CMCS-CLDPD 
and CLDPD suspensions showed lower cytotoxicity than 
PEI/DNA (P , 0.05), most probably due to good biodegrad-
ability and low toxicity of CMCS49 and cationic lipid LHLN20 
used in the preparation.
It was demonstrated that intratumoral pH value in solid 
tumors was around 6.5.50 Therefore, in the in vitro transfec-
tion test, the pH value of cell culture medium without serum 
was adjusted to 6.5 to mimic the acidic microenvironment 
of tumor cells. It was found that CMCS-CLDPD achieved 
similar transfection efficiency to CLDPD at pH 6.5 but with 
lower transfection efficiency at pH 7.4 (Figure 13). In order 
to further evaluate the pH sensitivity of CMCS-CLDPD 
in vivo, in vivo transfection efficiency was examined in 
tumor-bearing mice. Mice bearing B16 cells were subjected 
to an intratumoral injection of CMCS-CLDPD and CLDPD, 
and the gene expression efficiency in the isolated tumor cells 
was assayed. Anionic-charged CMCS-CLDPD displayed 
similar transfection efficiency to cationic-charged CLDPD 
(P . 0.05), which indicated that CMCS-CLDPD had pH 
sensitivity and the outermost layer of CMCS could fall off 
in the tumor tissue. Also, CMCS-CLDPD showed similar 
transfection efficiency to PEI/DNA (P . 0.05), which dem-
onstrated that CMCS-CLDPD had a great advantage over 
PEI/DNA in tumor tissue as CMCS-CLDPD displayed 
comparable transfection activity to PEI/DNA but with lower 
cytotoxicity (Figure 12).
Conclusion
In this work, a multifunctional nanovector with high 
  transfection efficiency was successfully constructed via 
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LbL technique. LbL technique is an easy method without 
use of organic solvents and complicated chemical modifica-
tion which helps to maintain biological activity of DNA. 
When the appropriate functional polyelectrolytes, such as 
nuclear localization peptide for enhanced nuclear delivery, 
fusogenic lipids or pH-sensitive polymers for endosomal 
escape, and ligands for specific targeting, were designed to 
construct multilayered vectors, the assembly vectors might 
contain nuclear targeting, endosomal escape, and cell 
uptake simultaneously to express high gene transfection 
efficiency. Therefore, LbL technique may furthermore be 
of great application value for the preparation of high effi-
cient and low cytotoxic multifunctional gene vectors. 
CMCS was demonstrated to be a pH-sensitive polymer 
which would be of great importance for the construction of 
antitumor gene vectors. Moreover, CMCS has –COOH 
and –NH2 groups which can be easily modified with a wide 
range of biomolecules and chemical ligands to achieve 
active targeting to tissues and cells. Further research will 
be directed towards the surface-modification of CMCS-
CLDPD with various kinds of ligands to achieve active 
targeting to tumor tissues for efficient gene delivery.
Acknowledgments
The work was supported by Program for New Century 
  Excellent Talents in University of China (NCET-08-0334) 
and Shandong Province Natural Science Foundation 
(ZR2009CM011).
Disclosure
The authors report no conflicts of interest in this work.
References
1.  Park K, Kim WJ, Cho YH, et al. Cancer gene therapy using 
adeno-associated virus vectors. Front Biosci. 2008;13:2653–2659.
2.  Morille M, Passirani C, Dufort S, et al. Tumor transfection after systemic 
injection of DNA lipid nanocapsules. Biomaterials. 2011;32(9): 
2327–2333.
3.  Wolff JA, Rozema DB. Breaking the bonds: non-viral vectors become 
chemically dynamic. Mol Ther. 2008;16(1):8–15.
4.  Bondi ML, Craparo EF. Solid lipid nanoparticles for applications in gene 
therapy: a review of the state of the art. Expert Opin Drug Deliv. 2010; 
7(1):7–18.
5.  Gao Y, Gu WW, Chen L, Xu Z, Li Y. A multifunctional nano device as 
non-viral vector for gene delivery: in vitro characteristics and   transfection. 
J Control Release. 2007;118(3):381–388.
6.  Kogure K, Akita H, Harashima H. Multifunctional envelope-type nano 
device for non-viral gene delivery: concept and application of Pro-
grammed Packaging. J Control Release. 2007;122(3):246–251.
7.  Decher G. Fuzzy nanoassemblies: toward layered polymeric multicom-
posites. Science. 1997;277(5330):1232–1237.
8.  Jewell CM, Lynn DM. Multilayered polyelectrolyte assemblies as plat-
forms for the delivery of DNA and other nucleic acid-based therapeutics. 
Adv Drug Deliv Rev. 2008;60(9):979–999.
  9.  Lin QK, Ren KF, Ji J. Hyaluronic acid and chitosan-DNA complex 
multilayered thin film as surface-mediated nonviral gene delivery 
system. Colloids Surf B Biointerfaces. 2009;74(1):298–303.
  10.  Saurer EM, Jewell CM, Kuchenreuther JM, Lynn DM. Assembly of 
erodible, DNA-containing thin films on the surfaces of polymer 
microparticles: toward a layer-by-layer approach to the delivery of 
DNA to antigen-presenting cells. Acta Biomater. 2009;5(3):913–924.
  11.  Blacklock J, You YZ, Zhou QH, Mao G, Oupicky D. Gene delivery 
in vitro and in vivo from bioreducible multilayered polyelectrolyte films 
of plasmid DNA. Biomaterials. 2009;30(5):939–950.
  12.  Zhang J, Chua LS, Lynn DM. Multilayered thin films that sustain the 
release of functional DNA under physiological conditions. Langmuir. 
2004;20(19):8015–8021.
  13.  Li P, Zhang N. Layer-by-layer self-assembly vectors for gene delivery. 
Curr Gene Ther. 2011;11(1):58–73.
  14.  Trubetskoy VS, Wong SC, Subbotin V , et al. Recharging cationic DNA 
complexes with highly charged polyanions for in vitro and in vivo gene 
delivery. Gene Ther. 2003;10(3):261–271.
  15.  Saul JM, Wang CHK, Ng CP, Pun SH. Multilayer nanocomplexes of 
polymer and DNA exhibit enhanced gene delivery. Adv Mater. 2008; 
20(1):19–25.
  16.  Ke JH, Young TH. Multilayered polyplexes with the endosomal 
  buffering polycation in the core and the cell uptake-favorable polycation 
in the outer layer for enhanced gene delivery. Biomaterials. 2010;31(35): 
9366–9372.
  17.  Cai K, Rechtenbach A, Hao J, Bossert J, Jandt KD. Polysaccharide-
protein surface modification of titanium via a layer-by-layer technique: 
characterization and cell behaviour aspects. Biomaterials. 2005;26(30): 
5960–5971.
  18.  Masuda T, Akita H, Harashima H. Evaluation of nuclear transfer and 
transcription of plasmid DNA condensed with protamine by 
  microinjection: the use of a nuclear transfer score. FEBS Lett. 2005; 
579(10):2143–2148.
  19.  Ye J, Wang A, Liu C, Chen Z, Zhang N. Anionic solid lipid nanoparticles 
supported on protamine/DNA complexes. Nanotechnology. 2008;19(28): 
285708.
  20.  Yu W, Liu C, Ye J, Zou W, Zhang N, Xu W. Novel cationic SLN con-
taining a synthesized single-tailed lipid as a modifier for gene delivery. 
Nanotechnology. 2009;20(21):215102.
  21.  Kim D, Lee ES, Oh KT, Gao ZG, Bae YH. Doxorubicin-loaded poly-
meric micelle overcomes multidrug resistance of cancer by double-
targeting folate receptor and early endosomal pH. Small. 2008;4(11): 
2043–2050.
 22.  Levy MS, Lotfian P, O’Kennedy R, Lo-Yim MY, Shamlou PA.   Quantitation 
of supercoiled circular content in plasmid DNA solutions using a 
  fluorescence-based method. Nucleic Acids Res. 2000;28(12):E57.
  23.  Han HD, Shin BC, Choi HS. Doxorubicin-encapsulated thermosensitive 
liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): 
drug release behavior and stability in the presence of serum. Eur J 
Pharm Biopharm. 2006;62(1):110–116.
  24.  Srinivasan C, Burgess DJ. Optimization and characterization of anionic 
lipoplexes for gene delivery. J Control Release. 2009;136(1):62–70.
  25.  Hu Y, Li K, Wang L, Yin S, Zhang Z, Zhang Y. Pegylated immuno-
lipopolyplexes: a novel non-viral gene delivery system for liver cancer 
therapy. J Control Release. 2010;144(1):75–81.
  26.  Park MR, Han KO, Han IK, et al. Degradable polyethylenimine- 
alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control 
Release. 2005;105(3):367–380.
  27.  Kamiya H, Akita H, Harashima H. Pharmacokinetic and pharmacody-
namic considerations in gene therapy. Drug Discov Today. 2003;8(21): 
990–996.
  28.  Liu C, Chen Z, Yu W, Zhang N. Novel cationic 6-lauroxyhexyl lysinate 
modified poly(lactic acid)-poly(ethylene glycol) nanoparticles enhance 
gene transfection. J Colloid Interface Sci. 2011;354(2):528–535.
  29.  Li P, Liu D, Sun X, Liu C, Liu Y, Zhang N. A novel cationic liposome 
formulation for efficient gene delivery via a pulmonary route. 
  Nanotechnology. 2011;22(24):245104.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
938
Li et alInternational Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology in 
diagnostics, therapeutics, and drug delivery systems throughout the 
biomedical field. This journal is indexed on PubMed Central, MedLine, 
CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal 
Citation Reports/Science Edition, EMBase, Scopus and the Elsevier 
Bibliographic databases. The manuscript management system is 
completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2012:7
  30.  Kunath K, von Harpe A, Petersen H, et al. The structure of 
PEG-modified poly(ethylene imines) influences biodistribution and 
pharmacokinetics of their complexes with NF-kappa B decoy in mice. 
Pharm Res. 2002;19(6):810–817.
  31.  van Vlerken LE, Vyas TK, Amiji MM. Poly(ethylene glycol)-modified 
nanocarriers for tumor-targeted and intracellular delivery. Pharm Res. 
2007;24(8):1405–1414.
  32.  Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M, Wagner E. 
Tumor-targeted gene therapy: strategies for the preparation of ligand-
polyethylene glycol-polyethylenimine/DNA complexes. J Control 
Release. 2003;91(1–2):173–181.
  33.  Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K, Seymour LW. 
Importance of lateral and steric stabilization of polyelectrolyte gene 
delivery vectors for extended systemic circulation. Mol Ther. 2002;5(4): 
463–472.
  34.  Guo W, Lee RL. Receptor-targeted gene delivery via folate-conjugated 
polyethylenimine. AAPS Pharm Sci. 1999;1(4):E19.
  35.  Rudolph C, Schillinger U, Plank C, et al. Nonviral gene delivery to the 
lung with copolymer-protected and transferrin-modified   polyethylenimine. 
Biochim Biophys Acta. 2002;1573(1):75–83.
  36.  Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient 
supply, and metabolic microenvironment of human tumors: a review. 
Cancer Res. 1989;49(23):6449–6465.
  37.  Guo X, Szoka FC Jr. Steric stabilization of fusogenic liposomes by a 
low-pH sensitive PEG – diortho ester – lipid conjugate. Bioconjug 
Chem. 2001;12(2):291–300.
  38.  Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical 
nanocarriers. Eur J Pharm Biopharm. 2009;71(3):431–444.
  39.  Fella C, Walker GF, Ogris M, Wagner E. Amine-reactive pyridylhy-
drazone-based PEG reagents for pH-reversible PEI polyplex shielding. 
Eur J Pharm Sci. 2008;34(4–5):309–320.
  40.  Li Y, Du Y, Tang Y, Wang X. A novel pH-sensitive and freeze-thawed 
carboxymethyl chitosan/poly(vinyl alcohol) blended hydrogel for 
protein delivery. Polym Int. 2009;58(10):1120–1125.
  41.  Chen L, Du Y, Wu H, Xiao L. Relationship between molecular structure 
and moisture-retention ability of carboxymethyl chitin and chitosan.   
J Appl Polym Sci. 2002;83(6):1233–1241.
  42.  Dubas ST, Schlenoff JB. Factors controlling the growth of polyelec-
trolyte multilayers. Macromolecules. 1999;32(24):8153–8160.
  43.  Steitz R, Jaeger W, von Klitzing R. Influence of charge density and 
ionic strength on the multilayer formation of strong polyelectrolytes. 
Langmuir. 2001;17(15):4471–4474.
  44.  Kujawa P, Moraille P, Sanchez J, Badia A, Winnik FM. Effect of 
molecular weight on the exponential growth and morphology of 
hyaluronan/chitosan multilayers: a surface plasmon resonance spec-
troscopy and atomic force microscopy investigation. J Am Chem Soc. 
2005;127(25):9224–9234.
  45.  Kabanov AV. Polymer genomics: an insight into pharmacology and 
toxicology of nanomedicines. Adv Drug Deliv Rev. 2006;58(15): 
1597–1621.
  46.  Choksakulnimitr S, Masuda S, Tokuda H, Takakura Y, Hashida M.   
In vitro cytotoxicity of macromolecules in different cell culture systems. 
J Control Release. 1995;34(3):233–241.
  47.  Daum N, Neumeyer A, Wahl B, Bur M, Lehr CM. In vitro systems for 
studying epithelial transport of macromolecules. Methods Mol Biol. 
2009;480:151–164.
  48.  Vega-Villa KR, Takemoto JK, Yanez JA, Remsberg CM, Forrest ML, 
Davies NM. Clinical toxicities of nanocarrier systems. Adv Drug Deliv 
Rev. 2008;60(8):929–938.
  49.  Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. A novel pH-
sensitive hydrogel composed of N,O-carboxymethyl chitosan and 
alginate cross-linked by genipin for protein drug delivery. J Control 
Release. 2004;96(2):285–300.
  50.  Matsumura Y, Kataoka K. Preclinical and clinical studies of anticancer 
agent-incorporating polymer micelles. Cancer Sci. 2009;100(4): 
572–579.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
939
Multifunctional nanovector assembled via layer-by-layer technique